Parsons James T.

CIK 00017598553 companiesMINNEAPOLIS, MN

SEC Profile

Transactions

Companies

Filings

CIK

0001759855

Recent Transactions

31 trades

Award
DiaMedica Therapeutics Inc.$DMAC
Stock Option (right to buy)
2026-06-01+51,189→ 51,189 total
Award
ONCOLYTICS BIOTECH INC$ONCY
Stock Option
2026-06-01+30,000→ 30,000 total
Purchase
ONCOLYTICS BIOTECH INC$ONCY
Common Shares
2026-03-11$1.03/sh+10,000→ 41,849 total
Award
DiaMedica Therapeutics Inc.$DMAC
Common Stock
2026-01-02$8.42/sh+10,095→ 97,949 total
Exercise/Conversion
DiaMedica Therapeutics Inc.$DMAC
Common Stock
2025-11-21$2.20/sh+12,000→ 87,854 total
Exercise/Conversion
DiaMedica Therapeutics Inc.$DMAC
Stock Option (right to buy)
2025-11-21−12,000→ 0 total
Award
DiaMedica Therapeutics Inc.$DMAC
Stock Option (right to buy)
2025-06-01+40,739→ 40,739 total
Award
DiaMedica Therapeutics Inc.$DMAC
Voting Common Shares, no par value per share
2025-01-02$5.34/sh+15,917→ 75,854 total
Award
DiaMedica Therapeutics Inc.$DMAC
Stock Option (right to buy)
2025-01-02+4,287→ 4,287 total
Award
DiaMedica Therapeutics Inc.$DMAC
Stock Option (right to buy)
2024-06-01+28,472→ 28,472 total
Award
DiaMedica Therapeutics Inc.$DMAC
Voting Common Shares, no par value per share
2024-01-02$2.80/sh+21,428→ 59,937 total
Award
DiaMedica Therapeutics Inc.$DMAC
Stock Option (right to buy)
2023-06-01+16,968→ 16,968 total
Award
DiaMedica Therapeutics Inc.$DMAC
Stock Option (right to buy)
2022-06-01+13,222→ 13,222 total
Award
DiaMedica Therapeutics Inc.$DMAC
Voting Common Shares, no par value per share
2022-01-03$3.58/sh+16,773→ 38,509 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−36,204→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−30,171→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−94,792→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−30,171→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−5,761→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−59,896→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−24,390→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−180,000→ 0 total
Award
DiaMedica Therapeutics Inc.$DMAC
Stock Option (right to buy)
2021-07-15+9,393→ 9,393 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-08−8,505→ 5,761 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-01-08$7.24/sh+8,505→ 8,505 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-01-08$15.79/sh−8,505→ 0 total
Award
DiaMedica Therapeutics Inc.$DMAC
Voting Common Shares, no par value per share
2021-01-01$8.23/sh+7,745→ 21,947 total
Award
DiaMedica Therapeutics Inc.$DMAC
Voting Common Shares, no par value per share
2020-06-01$4.59/sh+8,102→ 14,202 total
Award
DiaMedica Therapeutics Inc.$DMAC
Stock Option (right to buy)
2020-06-01+13,306→ 13,306 total
Award
DiaMedica Therapeutics Inc.$DMAC
Stock Option (right to buy)
2019-06-24+12,950→ 12,950 total
Purchase
DiaMedica Therapeutics Inc.$DMAC
Voting Common Shares, no par value per share
2018-12-11$4.00/sh+2,250→ 6,100 total

Companies

Recent Filings

Address

301 CARLSON PARKWAY SUITE 210

MINNEAPOLIS, MN, 55305

View on SEC.gov